A Novel Technique for Treatment of Recurrent Capsular Contracture Using Acellular Dermal Matrix in Aesthetic Revisional Breast Surgery

Capsular contracture remains among the most commonly cited reasons for reoperation following implant-based breast augmentation. The introduction of acellular dermal matrix (ADM) in revision surgery has led to a decrease in the recurrence of capsular contracture. However, there remains a relative paucity of literature in secondary aesthetic surgery and its use is associated with increased patient costs. The authors describe a novel technique using segmental interpositional graft placement to treat and prevent contracture recurrence while decreasing additional costs to the patient. This study is a retrospective chart review of patients who presented with recurrent capsular contractures and underwent revision surgery by a single surgeon. Patient demographics, treatment history, and postoperative complications were recorded. Five patients (7 breasts) were identified. Mean age was 36 years old and mean body mass index was 20.6 kg/m2 (range, 18.1-24.6 kg/m2). All 5 patients had prior surgical treatment for capsular contractures with recurrence. Mean follow-up was 52.8 months (range, 36-60 months). One patient experienced a recurrence in an untreated pole of the breast. The remaining patients did not experience recurrent capsular contracture to date. Multiple studies have shown the benefit of using ADM in the prevention or treatment of capsular contracture. The author’s technique may be an effective strategy to treat recurrent capsular contractures while decreasing the patients’ out-of-pocket costs